AI as Enterprise-Wide Enabler of Clinical Trial Innovation – with Leaders from Medable, Takeda, Sanofi, Novartis, and Daiichi Sankyo
This article is sponsored by Medable and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page. Clinical trials are becoming increasingly complex as pharmaceutical companies pursue more personalized therapies, navigate tighter timelines, and expand access…